Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.
Adult
Aged
Arrhythmias, Cardiac
/ diagnostic imaging
Contrast Media
/ administration & dosage
Death, Sudden, Cardiac
/ etiology
Female
Fibrosis
Gadolinium
/ administration & dosage
Heart
/ diagnostic imaging
Humans
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Mitral Valve Insufficiency
/ diagnostic imaging
Mitral Valve Prolapse
/ complications
Retrospective Studies
Cine magnetic resonance imaging
Gadolinium
Prolapsed mitral valve
T1 mapping
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
11
03
2018
accepted:
27
06
2018
revised:
01
06
2018
pubmed:
9
8
2018
medline:
26
3
2019
entrez:
9
8
2018
Statut:
ppublish
Résumé
To evaluate the incidence of late-gadolinium-enhancement (LGE) in mitral valve prolapse (MVP) (in the absence of other heart/valvular diseases), and its association with the degree of mitral regurgitation (MR) and/or with complex ventricular arrhythmia (ComVA), and to analyse the role of T1 mapping in the evaluation of MVP patients. We included all consecutive patients with MVP who underwent during 2015-2016 a comprehensive cardiac magnetic resonance (CMR) examination at 1.5 T. We evaluated the association of LGE with the MR fraction and the presence of ComVA. We compared myocardial T1-native and post-contrast times and extracellular volume (ECV)-values between MVP patients, both with and without LGE, and the control group. Thirty-four patients with MVP were selected (56 ± 14 years old, 59% male). All patients had MR; LGE and ComVA were present in 15 (44%) and 11 (34%) patients, respectively. Significant associations of LGE with both MR severity and ComVA were not found (p=0.72 and 0.79, respectively). T1 mapping confirmed the presence of LGE in all cases. In one patient a thin signal alteration resulted in more evident T1 mapping than LGE. Patients with MVP had higher native T1-values, lower post-contrast T1-values and increased ECV-values compared with controls (p=0.01, 0.01 and 0.00, respectively). Focal fibrosis with LGE was found in about half the MVP patients and it was independent of the degree of the valve dysfunction and the presence of ComVA. T1 mapping allows diffuse myocardial wall alterations to be identified, but no significant associations between the MR severity and ComVA and T1/ECV values were found. • MVP is a common valvulopathy affecting 2-3% of the general population. • MVP has been associated with an increased risk of arrhythmic complications and sudden cardiac death. • CMR is a non-invasive imaging method that provides a precise and more accurate assessment of patients with MVP.
Identifiants
pubmed: 30088066
doi: 10.1007/s00330-018-5634-5
pii: 10.1007/s00330-018-5634-5
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1546-1554Références
N Engl J Med. 1999 Jul 1;341(1):1-7
pubmed: 10387935
Int J Cardiovasc Imaging. 2002 Feb;18(1):539-42
pubmed: 12135124
J Heart Valve Dis. 2004 Jul;13(4):600-7
pubmed: 15311866
J Cardiovasc Magn Reson. 2006;8(3):503-7
pubmed: 16755839
JACC Cardiovasc Imaging. 2008 May;1(3):294-303
pubmed: 19356441
Circulation. 2009 Aug 18;120(7):577-84
pubmed: 19652094
J Am Coll Cardiol. 2010 Jul 6;56(2):89-97
pubmed: 20620723
J Am Coll Cardiol. 2011 Feb 22;57(8):891-903
pubmed: 21329834
Eur Heart J. 2012 May;33(10):1268-78
pubmed: 22279111
Circ Cardiovasc Imaging. 2013 May 1;6(3):373-83
pubmed: 23553570
Methodist Debakey Cardiovasc J. 2013 Jul-Sep;9(3):142-8
pubmed: 24066197
J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132
pubmed: 24939033
Eur J Clin Invest. 2014 Sep;44(9):840-7
pubmed: 25066426
Circ Cardiovasc Imaging. 2014 Nov;7(6):946-53
pubmed: 25140067
Radiographics. 2014 Oct;34(6):1594-611
pubmed: 25310419
J Am Coll Cardiol. 2015 Mar 24;65(11):1078-88
pubmed: 25790878
Circulation. 2015 Aug 18;132(7):556-66
pubmed: 26160859
Heart Rhythm. 2016 Feb;13(2):498-503
pubmed: 26416619
JACC Cardiovasc Imaging. 2016 Jan;9(1):54-63
pubmed: 26762875
Circulation. 2016 Mar 29;133(13):e458
pubmed: 27022045
J Am Coll Cardiol. 2016 May 17;67(19):2289-2294
pubmed: 27173039
Circ Res. 2016 Jul 8;119(2):341-56
pubmed: 27390336
Heart. 2017 Feb;103(3):204-209
pubmed: 27515954
Circ Cardiovasc Imaging. 2016 Aug;9(8):e005030
pubmed: 27516479
J Thorac Dis. 2016 Aug;8(8):E827-8
pubmed: 27620164
Clinicoecon Outcomes Res. 2016 Oct 18;8:613-627
pubmed: 27799803
J Thorac Dis. 2017 Dec;9(12):5390-5398
pubmed: 29312750
Circulation. 1971 Jul;44(1):130-42
pubmed: 4104697
Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 1):387-93
pubmed: 7681188
J Am Coll Cardiol. 1994 Mar 15;23(4):951-8
pubmed: 8106701
Am J Cardiol. 1998 Mar 15;81(6):792-5
pubmed: 9527098